Please login to the form below

Not currently logged in
Email:
Password:

medical affairs

This page shows the latest medical affairs news and features for those working in and with pharma, biotech and healthcare.

Long-serving R&D head Bischofberger to leave Gilead

Long-serving R&D head Bischofberger to leave Gilead

McHutchison has been at Gilead since 2010, joining the company from Duke University Medical Center, and has been a key figure in the company hepatitis development programmes. ... He’ll retain that responsibility after becoming CMO and add in leadership

Latest news

More from news
Approximately 1 fully matching, plus 183 partially matching documents found.

Latest Intelligence

  • A marathon and a sprint A marathon and a sprint

    Roles are evolving. Whereas historically medical teams rarely engaged customers, stakeholder engagement is now more medically focused. ... We may eventually see a complete role reversal where market access, medical and government affairs become the

  • Accelerating innovation Accelerating innovation

    Research strategy. Alexandre has been with the company for five years, having previously held clinical development and medical affairs leadership roles with the likes of Sanofi and Novartis. ... Phase II results from its CABOSUN trial, in which it was

  • Evolve and thrive vs wait and wither Evolve and thrive vs wait and wither

    Collaboration with other functions, such as market access or medical affairs, is ad hoc and spontaneous.

  • Medical affairs Medical affairs

    medically qualified personnel, medical affairs has transformed into a role of strategic leadership. ... Beginning with the end in mind. So when should the medical affairs team get involved?

  • Can big data give medical affairs an edge in strategic planning? Can big data give medical affairs an edge in strategic planning?

    This can help medical affairs teams to plan and execute proactive, unbiased, scientific and dissemination-based strategies that are evidence supported. ... Such products can create and facilitate a valuable and logical measure of value for the work of

More from intelligence
Approximately 5 fully matching, plus 22 partially matching documents found.

Latest appointments

  • Nabriva Therapeutics appoints chief medical officer Nabriva Therapeutics appoints chief medical officer

    Dr Schranz joins Nabriva from Irish biopharma Shire, with nearly two decades of experience in clinical development and medical affairs. ... Dr Schran’z new role will see her lead clinical development and medical affairs, contributing to the company’s

  • Lilly appoints Maura Dickler as VP of late phase oncology development Lilly appoints Maura Dickler as VP of late phase oncology development

    In her new role at Lilly Oncology she will report to senior vice president, global development and medical affairs Levi Garraway. ... In addition to her role at Sloan Kettering, Dr Dickler concurrently serves as associate professor of medicine at New

  • Dr Sotirios Stergiopoulos leaves Shire for Ipsen Dr Sotirios Stergiopoulos leaves Shire for Ipsen

    Ipsen has promoted Dr Sotirios Stergiopoulos from global medical affairs to chief medical officer. ... He first joined the French biopharma firm from Baxalta - now Shire - last year, where he served as vice president, head of global medical affairs

  • Linda Law joins Advicenne as US VP, clinical development and med affairs Linda Law joins Advicenne as US VP, clinical development and med affairs

    She will oversee the biopharma’s developments with its dTRA candidate. Late-stage biopharmaceutical company Advicenne has appointed Linda Law as its new US vice president of clinical development and medical ... She brings 20 years’of experience in

  • Swiss biotech Inositec appoints new chief medical officer Swiss biotech Inositec appoints new chief medical officer

    Swiss biotech Inositec appoints new chief medical officer. Dr Frits van Alphen joins the group from Roche. ... Dr van Alphen joins from Roche, where he headed its operational excellence team and prior to this he was chief medical officer at Vifor Pharma,

More from appointments
Approximately 0 fully matching, plus 88 partially matching documents found.

Latest from PMHub

  • Value Genome LLC

    Value Genome LLC. Assisting mid to late stage clinical development prepare for their first commercialization specializing in market access strategies, medical affairs, health economics, pricing and reimbursement.

  • Ashfield U.S. hires two senior executives for new Medical Affairs business unit

    Ashfield U.S. hires two senior executives for new Medical Affairs business unit. ... Commenting on the appointments and launch of the Medical Affairs business unit, Greg Flynn, President Ashfield U.S.

  • Eames.Jones.Judge.Hawkings

    We recruit from executive level upwards in medical, clinical research, regulatory affairs, sales, marketing, R&D, quality control, production, human resources, general management, and market research.

More from PMHub
Approximately 0 fully matching, plus 3 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics